Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Vaccine adjuvant")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 52

  • Page / 3
Export

Selection :

  • and

The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effectCALABRO, Samuele; TRITTO, Elaine; PEZZOTTI, Annamaria et al.Vaccine. 2013, Vol 31, Num 33, pp 3363-3369, issn 0264-410X, 7 p.Article

European union regulatory developments for new vaccine adjuvants and delivery systemsSESARDIC, Dorothea; DOBBELAER, Roland.Vaccine. 2004, Vol 22, Num 19, pp 2452-2456, issn 0264-410X, 5 p.Conference Paper

Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2ASCRUTEN, Erin; KOVACS-NOLAN, Jennifer; GRIEBEL, Philip J et al.Vaccine. 2010, Vol 28, Num 17, pp 2945-2956, issn 0264-410X, 12 p.Article

Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvantTUNG, Chun-Yu; LEWIS, David E; LING HAN et al.Vaccine. 2014, Vol 32, Num 42, pp 5411-5419, issn 0264-410X, 9 p.Article

A practical approach to the use of nanoparticles for vaccine deliveryWENDORF, Janet; SINGH, Manmohan; CHESKO, James et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 12, pp 2738-2750, issn 0022-3549, 13 p.Article

Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvantsKLINMAN, Dennis M; KLASCHIK, Sven; TOMARU, Koji et al.Vaccine. 2010, Vol 28, Num 8, pp 1919-1923, issn 0264-410X, 5 p.Conference Paper

Structure and adsorption properties of commercial calcium phosphate adjuvantDONGPING JIANG; PREMACHANDRA, Gnanasiri S; JOHNSTON, Cliff et al.Vaccine. 2004, Vol 23, Num 5, pp 693-698, issn 0264-410X, 6 p.Article

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI responseHENRIKSEN-LACEY, Malou; CHRISTENSEN, Dennis; BRAMWELL, Vincent W et al.Journal of controlled release. 2010, Vol 145, Num 2, pp 102-108, issn 0168-3659, 7 p.Article

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal modelsATAMAN-ÖNAL, Yasemin; MUNIER, Séverine; VERRIER, Bernard et al.Journal of controlled release. 2006, Vol 112, Num 2, pp 175-185, issn 0168-3659, 11 p.Article

Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonistsPERI, Francesco; PIAZZA, Matteo.Biotechnology advances. 2012, Vol 30, Num 1, pp 251-260, issn 0734-9750, 10 p.Article

Local cytokine and inflammatory responses to candidate vaginal adjuvants in miceLINDQVIST, Madelene; NAVABI, Nazanin; JANSSON, Marianne et al.Vaccine. 2010, Vol 28, Num 1, pp 270-278, issn 0264-410X, 9 p.Article

Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccineHAGENAARS, Niels; VERHEUL, Rolf J; MOOREN, Imke et al.Journal of controlled release. 2009, Vol 140, Num 2, pp 126-133, issn 0168-3659, 8 p.Article

Enhanced immune response induced by BSA loaded in hydroxyethylstarch microparticlesBALASSE, Emilie; ODOT, Johann; GATOUILLAT, Gregory et al.International journal of pharmaceutics. 2008, Vol 353, Num 1-2, pp 131-138, issn 0378-5173, 8 p.Article

Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccineCHENGJI CUI; STEVENS, Vernon C; SCHWENDEMAN, Steven P et al.Vaccine. 2007, Vol 25, Num 3, pp 500-509, issn 0264-410X, 10 p.Article

Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytesHWANG, Shen-An; WILK, Katarzyna M; BANGALE, Yogesh A et al.Medical microbiology and immunology. 2007, Vol 196, Num 3, pp 171-180, issn 0300-8584, 10 p.Article

Aluminum Adjuvant Dose Guidelines in Vaccine Formulation for Preclinical EvaluationsVECCHI, Simone; BUFALI, Simone; SKIBINSKI, David A. G et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 1, pp 17-20, issn 0022-3549, 4 p.Article

Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvantPINGLI LI; HAINING TAN; DONGQING XU et al.Carbohydrate polymers. 2014, Vol 110, pp 446-455, issn 0144-8617, 10 p.Article

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in RomaniaFOX, Christopher B; HUYNH, Chuong; O'HARA, Michael K et al.Vaccine. 2013, Vol 31, Num 12, pp 1633-1640, issn 0264-410X, 8 p.Article

The vaccine adjuvant extra domain A from fibronectin retains its proinflammatory properties when expressed in tobacco chloroplastsFARRAN, Inmaculada; MCCARTHY-SUAREZ, Iva; RIO-MANTEROLA, Francisco et al.Planta. 2010, Vol 231, Num 4, pp 977-990, issn 0032-0935, 14 p.Article

Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccinationALINE, Fleur; BRAND, Denys; PIERRE, Josette et al.Vaccine. 2009, Vol 27, Num 38, pp 5284-5291, issn 0264-410X, 8 p.Article

Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosisHWANG, Shen-An; WILK, Katarzyna M; BUDNICKA, Monika et al.Vaccine. 2007, Vol 25, Num 37-38, pp 6730-6743, issn 0264-410X, 14 p.Article

Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in miceSTERTMAN, Linda; STRINDELIUS, Lena; SJÖHOLM, Ingvar et al.Vaccine. 2004, Vol 22, Num 21-22, pp 2863-2872, issn 0264-410X, 10 p.Article

Streptococcus equi antigens adsorbed onto surface modified poly-e-caprolactone microspheres induce humoral and cellular specific immune responsesFLORINDO, H. F; PANDIT, S; GONCALVESA, L. M. D et al.Vaccine. 2008, Vol 26, Num 33, pp 4168-4177, issn 0264-410X, 10 p.Article

Recent progress concerning CpG DNA and its use as a vaccine adjuvantSHIROTA, Hidekazu; KLINMAN, Dennis M.Expert review of vaccines. 2014, Vol 13, Num 2, pp 299-312, issn 1476-0584, 14 p.Article

Bacterial Protein Toxins : Current and Potential Clinical UseFABBRI, A; TRAVAGLIONE, S; FALZANO, L et al.Current medicinal chemistry. 2008, Vol 15, Num 11, pp 1116-1125, issn 0929-8673, 10 p.Article

  • Page / 3